Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling

SIMPLE SUMMARY: Breast cancer patients often receive anti-hormonal treatment if their tumor is positive for the Estrogen Receptor (ER), but tumors may become resistant to this therapy and still metastasize. We studied 101 of such metastatic lesions and investigated these lesions for mutated genes an...

Descripción completa

Detalles Bibliográficos
Autores principales: Angus, Lindsay, Smid, Marcel, Wilting, Saskia M., Bos, Manouk K., Steeghs, Neeltje, Konings, Inge R. H. M., Tjan-Heijnen, Vivianne C. G., van Riel, Johanna M. G. H., van de Wouw, Agnes J., Cuppen, Edwin, Lolkema, Martijn P., Jager, Agnes, Sleijfer, Stefan, Martens, John W. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487136/
https://www.ncbi.nlm.nih.gov/pubmed/37686693
http://dx.doi.org/10.3390/cancers15174416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487136/
https://www.ncbi.nlm.nih.gov/pubmed/37686693
http://dx.doi.org/10.3390/cancers15174416

Ejemplares similares